CN1320445A - Chinese-medicinal pill for treating rheumatoid arthritis - Google Patents
Chinese-medicinal pill for treating rheumatoid arthritis Download PDFInfo
- Publication number
- CN1320445A CN1320445A CN01106577A CN01106577A CN1320445A CN 1320445 A CN1320445 A CN 1320445A CN 01106577 A CN01106577 A CN 01106577A CN 01106577 A CN01106577 A CN 01106577A CN 1320445 A CN1320445 A CN 1320445A
- Authority
- CN
- China
- Prior art keywords
- radix
- rheumatoid arthritis
- chinese patent
- rhizoma
- patent medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese patent medicine in the form of pill for treating rheumatoid arthritis is prepared from 30 Chinese-medicinal materials including earthworm, pipefish, cinammon twigs, white peony root, etc. Its advantages are high curative effect and no recurrence.
Description
The present invention relates to Chinese patent medicine, relate to a kind of Chinese patent medicine ball that is used for the treatment of rheumatoid arthritis specifically.
Rheumatoid arthritis is the disease based on chronic general arthralgia.Have clinically multiple, the characteristics of symmetry arthralgia, swelling, but acute attack, but also spontaneous remission, but tend to cause the irreversible stiff and ossified sex deviation in joint, the disability rate height does not still have specific short at present.Belong in Chinese medicine " arthromyodynia ", because its course of disease is long, touching difficulty heals, so be called " insensitive impediment ".Though many pharmaceutical trials are arranged in this disease of treatment both at home and abroad, be not because curative effect is not good enough recent decades, can not be accepted by the patient too greatly because of side effect exactly.
Motherland's tcm theory is thought, rheumatoid is because the Liver and kidney weakness, wind-cold damp pathogen is invaded joint, meridians in an opponent's defence, cause the QI and blood retardance, move not smooth, cause that pain, tingle, arthroncus, joint stuffiness take place at position such as muscle BJM, belong to the disease of deficiency in origin and excess in superficiality, sharply outbreak during often because of climate change.Modern medicine thinks that rheumatoid arthritis is a kind of autoimmune disease of non-special originality, and companion's blood flow is learned and changed and the microcirculation change, and in stage of attack, hemorheological indexes is worth height than the normal person.The inventor of present patent application finds through further investigation, " gold is deficient " Ramulus Cinnamomi paeoniae and Anemarrhenae Decoction can improve hemorheology, make whole blood viscosity (ratio), plasma viscosity (ratio), erythrocyte electrophoretic time (second) that obvious decline be arranged, can make above-mentioned three indexs be tending towards recovering normal, microcirculation improvement.And insect medicine has the effect of stronger dispelling wind and removing obstruction in the collateral pain relieving, and utilization is appropriate, can play brave husband's merit.Radix Tripterygii Wilfordii is that Chinese medicine is used for the treatment of the medicine that rheumatoid first-selection must be used, and this medicine has had that prostaglandin generates inhibitory action and onset is very fast, and stronger humoral immunization inhibitory action is arranged.
Purpose of the present invention just is to overcome above-mentioned weak point of the prior art, and based on above-mentioned tcm theory, provides a kind of from setting about with blood-supplementing blood-nourishing, liver and kidney tonifying, reaches the Chinese patent medicine ball of the treatment rheumatoid arthritis for the treatment of both the principal and secondary aspects of a disease.
Purpose of the present invention can realize by following measure:
The Chinese patent medicine ball of treatment rheumatoid arthritis of the present invention is formed by pure Chinese medicine medical material compatibility, and the ratio of weight and number of its pharmaceutical formulation is as follows: Gekko Swinhonis 6-15g, Pheretima 6-20g, Solenognathus 6-10g, Radix Tripterygii Wilfordii 6-15g, Ramulus Cinnamomi 6-15g, Radix Paeoniae Alba 10-25g, Rhizoma Anemarrhenae 10-15g, Radix Glycyrrhizae 6-10g, Herba Ephedrae 6-10g, Rhizoma Atractylodis Macrocephalae 6-15g, Radix Aconiti Lateralis Preparata 6-10g, Radix Saposhnikoviae 6-10g, Radix Stephaniae Tetrandrae 5-15g, Radix Astragali 10-30g, Radix Angelicae Sinensis 10-15g, Rhizoma Chuanxiong 10-15g, field Herba Cistanches 10-30g, Typhonium flagelliforme (Lodd.) Blume 6-10g, eupolyphaga 5-10g, black Folium 6-15g, Zaocys 5-10g, Fructus Lycii 10-20g, Semen Sinapis Albae 10-20g.
Also contain following medicine in the Chinese patent medicine ball of the present invention, the ratio of weight and number of its prescription is as follows: Poria 10-15g, Scorpio 6-10g, Scolopendra 2-5g, Herba Taxilli 10-30g, Radix Cyathulae 6-10g, Rhizoma Gastrodiae 6-15g, Hirudo 3-6g.
The preparation method of this Chinese patent medicine ball is conventional preparation method, can be with the common pulverization of said medicine, and making pellets by mixing medical powder with honey is patent medicine.
The present invention adds tonification healthy energy, activating blood circulation to dissipate blood stasis and a large amount of insect medicine and forms with " gold is deficient " Ramulus Cinnamomi paeoniae and Anemarrhenae Decoction.The Radix Astragali, Radix Angelicae Sinensis, Radix Paeoniae Alba benefiting QI and nourishing blood in the side; Black Folium, field Herba Cistanches, Herba Taxilli, Fructus Lycii, the Rhizoma Atractylodis Macrocephalae, Radix Aconiti Lateralis Preparata liver and kidney tonifying and spleen invigorating are to fill the source of the five internal organs; Ramulus Cinnamomi, Herba Ephedrae, Radix Saposhnikoviae etc., the letter that dispels the wind is wet, warming the meridian for promoting the flow of YANG QI, with Xie Qibiao; Clearing away heat and nourishing YIN, nourishing blood to suppress the hyperactive liver such as the Radix Paeoniae Alba, the Rhizoma Anemarrhenae, Radix Glycyrrhizae, with its in; Moreover Ramulus Cinnamomi, the Radix Paeoniae Alba, the Rhizoma Anemarrhenae can improve rheology, make whole blood viscosity (ratio), plasma viscosity (ratio), erythrocyte electrophoretic time (second) that obvious decline be arranged, and can make above-mentioned three indexs be tending towards recovering normal, microcirculation improvement.And insect medicine has the effect of stronger dispelling wind and removing obstruction in the collateral pain relieving, and utilization is appropriate, can play brave husband's merit.Zaocys can be searched and pick the wet to remove insensitive impediment of muscles and bones meridians, is that other medicines are irreplaceable; And the Semen Sinapis Albae outer wet disease of flesh side film that disappears in order to the joint, also is that other medicines are irreplaceable; Rhizoma Chuanxiong, Typhonium flagelliforme (Lodd.) Blume are first choice of activating blood circulation to dissipate blood stasis, the removing obstruction in the collateral to relieve pain; Radix Tripterygii Wilfordii then is that Chinese medicine is used for the treatment of the medicine that rheumatoid first-selection must be used, and this medicine has had that prostaglandin generates inhibitory action and onset is very fast, and stronger humoral immunization inhibitory action is arranged.
In sum, Chinese patent medicine ball of the present invention is set about from blood-supplementing blood-nourishing, liver and kidney tonifying, doublely dispels the wind, promoting blood circulation to remove obstruction in the collateral, cold expelling removing dampness, has treating both the principal and secondary aspects of a disease, evident in efficacy, the advantage consolidated.
The Chinese patent medicine ball of treatment rheumatoid arthritis of the present invention generally took effect in the back of taking medicine through the clinical observation to 54 routine patients (course of disease is the shortest 6 months, and is the longest 32 years for wherein male 10 examples, women 44 examples) in 3-10 days; Wherein produce effects 32 examples account for 60%; Effective 21 examples account for 38%; Invalid 1 example accounts for 2%; Total effective rate 98%.For details see attached table:
Table 1: observation index
| Observation item (meansigma methods) | Deadlock in morning (branch) | The arthralgia number | The arthroncus number |
| The example number | ????54 | ????54 | ????54 |
| Before the treatment | ????212 | ????21.24 | ????14.53 |
| After the treatment | ????21 | ????8.04 | ????2.94 |
| ????P | ????＜0.01 | ????＜0.01 | ????＜0.01 |
| Improvement % | ????90 | ????50 | ????72 |
Table 2: treatment group and contrast therapeutic effect comparison sheet
| Case load | Effective routine number | Invalid routine number | Effective percentage | Differential meaning | |
| The treatment group | ????54 | ????53 | ????1 | ????98％ | Differ remarkable |
| Matched group | ????20 | ????12 | ????8 | ????60％ |
Annotate: the diagnosis of above-mentioned clinical observation and criterion adopt " rheumatoid arthritis combination of Chinese and Western medicine diagnosis and treatment standard " that the diagnostic criteria of U.S. rheumatism association the 51st ARA meeting revision June in 1987 and first national combination of Chinese and Western medicine rheumatism science that China holds in Kunming in April, 1988 revises after the meeting as the diagnositc decision standard: promptly 1, the swollen joint of getting involved is painful, 2, the function of joint moving obstacle, 3, arthralgia, 4, then be judged to effectively if any two persons of taking effect in four standards of deadlock etc. in morning, wherein three persons of taking effect then are judged to produce effects, take effect or do not see as only there being one that any improver then is judged to is invalid.
Matched group is treated for using other medicines (except hormone, the Radix Tripterygii Wilfordii preparation) in the table 2 curative effect and judgement curative effect, diagnostic criteria is all identical.
The present invention is described in further detail below with reference to embodiment:
Embodiment 1:
Get Gekko Swinhonis 10g, Pheretima 16g, Solenognathus 6g, Radix Tripterygii Wilfordii 8g, Ramulus Cinnamomi 10g, Radix Paeoniae Alba 15g, Rhizoma Anemarrhenae 10g, Radix Glycyrrhizae 6g, Herba Ephedrae 7g, Rhizoma Atractylodis Macrocephalae 15g, Radix Aconiti Lateralis Preparata 10g, Radix Saposhnikoviae 9g, Radix Stephaniae Tetrandrae 12g, Radix Astragali 20g, Poria 10g, Radix Angelicae Sinensis 10g, Rhizoma Chuanxiong 13g, Scorpio 8g, Scolopendra 5g, field Herba Cistanches 15g, Typhonium flagelliforme (Lodd.) Blume 10g, eupolyphaga 5g, Herba Taxilli 30g, black Folium 15g, Radix Cyathulae 6g, Rhizoma Gastrodiae 10g, Zaocys 5g, Fructus Lycii 20g, Hirudo 4g, the common pulverization of Semen Sinapis Albae 10g, making pellets by mixing medical powder with honey, every ball 9g.
Embodiment 2:
Get Gekko Swinhonis 6g, Pheretima 20g, Solenognathus 9g, Radix Tripterygii Wilfordii 6g, Ramulus Cinnamomi 15g, Radix Paeoniae Alba 20g, Rhizoma Anemarrhenae 15g, Radix Glycyrrhizae 8g, Herba Ephedrae 10g, Rhizoma Atractylodis Macrocephalae 6g, Radix Aconiti Lateralis Preparata 7g, Radix Saposhnikoviae 7g, Radix Stephaniae Tetrandrae 10g, Radix Astragali 25g, Poria 15g, Radix Angelicae Sinensis 14g, Rhizoma Chuanxiong 10g, Scorpio 10g, Scolopendra 3g, field Herba Cistanches 25g, Typhonium flagelliforme (Lodd.) Blume 6g, eupolyphaga 8g, Herba Taxilli 15g, black Folium 7g, Radix Cyathulae 9g, Rhizoma Gastrodiae 6g, Zaocys 9g, Fructus Lycii 12g, Hirudo 5g, the common pulverization of Semen Sinapis Albae 18g, making pellets by mixing medical powder with honey, every ball 9g.
Claims (2)
1, a kind of Chinese patent medicine ball for the treatment of rheumatoid arthritis, it is characterized in that: the ratio of weight and number of its pharmaceutical formulation is as follows: Gekko Swinhonis 6-15g, Pheretima 6-20g, Solenognathus 6-10g, Radix Tripterygii Wilfordii 6-15g, Ramulus Cinnamomi 6-15g, Radix Paeoniae Alba 10-25g, Rhizoma Anemarrhenae 10-15g, Radix Glycyrrhizae 6-10g, Herba Ephedrae 6-10g, Rhizoma Atractylodis Macrocephalae 6-15g, Radix Aconiti Lateralis Preparata 6-10g, Radix Saposhnikoviae 6-10g, Radix Stephaniae Tetrandrae 5-15g, Radix Astragali 10-30g, Radix Angelicae Sinensis 10-15g, Rhizoma Chuanxiong 10-15g, field Herba Cistanches 10-30g, Typhonium flagelliforme (Lodd.) Blume 6-10g, eupolyphaga 5-10g, black Folium 6-15g, Zaocys 5-10g, Fructus Lycii 10-20g, Semen Sinapis Albae 10-20g.
2, the Chinese patent medicine ball of treatment rheumatoid arthritis according to claim 1, it is characterized in that: also contain following medicine in the described Chinese patent medicine ball, the ratio of weight and number of its prescription is as follows: Poria 10-15g, Scorpio 6-10g, Scolopendra 2-5g, Herba Taxilli 10-30g, Radix Cyathulae 6-10g, Rhizoma Gastrodiae 6-15g, Hirudo 3-6g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB01106577XA CN1140284C (en) | 2001-03-24 | 2001-03-24 | Chinese-medicinal pill for treating rheumatoid arthritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB01106577XA CN1140284C (en) | 2001-03-24 | 2001-03-24 | Chinese-medicinal pill for treating rheumatoid arthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1320445A true CN1320445A (en) | 2001-11-07 |
| CN1140284C CN1140284C (en) | 2004-03-03 |
Family
ID=4655570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB01106577XA Expired - Fee Related CN1140284C (en) | 2001-03-24 | 2001-03-24 | Chinese-medicinal pill for treating rheumatoid arthritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1140284C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1977899B (en) * | 2005-12-03 | 2011-07-20 | 颜正东 | Medicine for treating rheumatoid arthritis |
| CN102872387A (en) * | 2012-10-11 | 2013-01-16 | 王慧艳 | Traditional Chinese medicine composition for treating arthralgia caused by wind-damp-heat pathogens |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101129597B (en) * | 2007-08-09 | 2011-09-21 | 倪慧文 | Orally taken traditional Chinese medicine for treating rheumatoid arthritis |
| CN101485835B (en) * | 2009-02-12 | 2012-02-01 | 北京市石景山区老医药卫生工作者协会模式口中医医院 | Medicament composition for treating ostarthritis as well as preparation method and detection method |
-
2001
- 2001-03-24 CN CNB01106577XA patent/CN1140284C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1977899B (en) * | 2005-12-03 | 2011-07-20 | 颜正东 | Medicine for treating rheumatoid arthritis |
| CN102872387A (en) * | 2012-10-11 | 2013-01-16 | 王慧艳 | Traditional Chinese medicine composition for treating arthralgia caused by wind-damp-heat pathogens |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1140284C (en) | 2004-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN103341079B (en) | Chinese medicine composition for treating acne | |
| CN102784333B (en) | Traditional Chinese medicine composition for curing eczema | |
| CN103877517A (en) | Traditional Chinese medicine for treating pneumonia | |
| CN102416145B (en) | Chinese medicinal composition for treating menstrual disorder | |
| CN102406870B (en) | Medicament for treating rheumatic arthralgia | |
| CN1140284C (en) | Chinese-medicinal pill for treating rheumatoid arthritis | |
| CN101040949B (en) | Medicine compound for creating rheumatism and rheumatoid arthritis and the preparing method and application | |
| CN1843421A (en) | Rheumatoid disease treating medicine | |
| CN101690797B (en) | Traditional Chinese medicine for treating rheumatism and rheumatoid diseases | |
| CN101439173A (en) | Chinese medicine prescription for treating rheumatic arthritis | |
| CN102366602A (en) | Traditional Chinese medicine formula used for treating rheumatism | |
| CN104645163A (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN103349767B (en) | Inula nervosa Wall oil capsule preparation and preparation method thereof | |
| CN104800443A (en) | Bone setting agent with functions of tonifying kidney and regenerating bone marrow | |
| CN103830422A (en) | Traditional Chinese medicine for treating amenorrhea | |
| CN103301374B (en) | Pharmaceutical composition for treating postpartum non-specificity vaginitis | |
| CN104013718A (en) | Field thistle decoction traditional Chinese medicine preparation | |
| CN115814040B (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation thereof | |
| CN103316133B (en) | Medicine for treating lame impediment | |
| CN102764325B (en) | Chinese medicinal composition for dispelling rheumatism and relieving pain | |
| CN108567926B (en) | Traditional Chinese medicine composition for treating blood stasis collateral blocking type autoimmune hepatitis and preparation method thereof | |
| CN1309412C (en) | Medicine composition for treating AIDS and preparing method thereof | |
| CN105435110A (en) | Ointment for treating chronic infectious arthritis | |
| CN105663869A (en) | Traditional Chinese medicinal composition for treating acute nephritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |